PCaI patient education conference: March 2, Ft. Myers, FL

Prostate Cancer International (PCaI) is excited to be holding its next patient education / information conference in Fort Myers, FL, on March 2, 2019, from 9:00 a.m. to 5:00 p.m. For complete details of the meeting agenda, the speakers, how to register, and other facts, please click here. … READ MORE …

Prostate ablation using HIFU — the role of patient preference information

A newly published review by staff of the Center for Devices and Radiological Health (CDRH at the U.S. Food & Drug Administration (FD) addresses the potential role for patient preference information (PPI) in determining patient perceptions of the “value” of high-intensity focused ultrasound (HIFU) and similar techniques in the management of prostate cancer. … READ MORE …

“If you can’t explain it simply, you don’t understand it well enough”

Many readers of this blog site might find this video (or the transcript) to be informative … or just entertaining. It’s primarily intended for physicians and their support staff.

Help with finding out about clinical trials for prostate cancer treatment

Apparently the National Cancer Institute (NCI) has just re-funded the Fred Hutchinson Cancer Research Center in Seattle to the tune of $24 million to continue to operate what we see as an important, patient-centric program here in the USA that we (and therefore probably many others) were utterly unaware of. … READ MORE …

Finding common ground on how “best” to treat localized prostate cancer, and what to tell the patients

One of the hardest issues for newly diagnosed prostate cancer patients to deal with has long been the differences in opinion between physicians about appropriate first-line treatment (and the relevant information they are offered) — most especially for patients with localized disease. … READ MORE …

Clinical trial design, clinical advice to patients, and clinical decision-making: not the same thing at all

In a recent opinion piece in the Journal of Clinical Oncology, Dr. Anthony D’Amico (a prostate cancer specialist for whom we have great respect) has again aired his concerns about risk for progression to metastatic disease among men on active surveillance. … READ MORE …

“Competitive analysis” in the development of drugs for advanced prostate cancer

So the other morning your sitemaster learned that a relatively new FirstWord Therapy Report had come out that dealt with future use of biopharmaceuticals in the treatment of progressive and advanced prostate cancer. … READ MORE …

What does “value” mean for prostate cancer patients?

Many readers who weren’t able to join us on yesterday’s CureTalk panel discussion may want to listen to what was a wide-ranging discussion about things that are really valuable to prostate cancers patients at diagnosis and along their prostate cancer journey. … READ MORE …

Satisfaction with “information provision” among Dutch prostate cancer patients

Sometimes — your sitemaster is willing to admit — he can become distinctly aggravated by the quality and conclusions of certain types of research related to the management of prostate cancer. … READ MORE …

Quality of life after standard therapies for localized prostate cancer

Assessment of patient quality of life (QoL) after standard forms of treatment for localized prostate cancer is difficult for many reasons — not least because there is no real agreement among members of the research community about the best ways to measure QoL or patient satisfaction after treatment. … READ MORE …

Preliminary data from SWOG/CRAB survey on patient/survivor needs

Last October we were able to assist the Southwest Oncology Group (SWOG) and Cancer Research and Biostatistics (CRAB) by asking readers to participate in an online survey dealing with the needs of patients (“survivors”) in providing follow-up cancer information after initial treatment for their cancer. The early results are in. … READ MORE …

What if you could see your personal health records on-line?

Here in the USA — and in some other countries too — there is an ongoing debate about whether patients should have broad access to their personal health records (including things like laboratory results, physician notes, etc.). … READ MORE …

Education about possible management options for prostate cancer BEFORE biopsy

Data from a small, recently published pilot study offers some interesting information about the impact of providing good quality educational information to patients about options for the management of prostate cancer before they were ever given their biopsy (i.e., before their diagnosis of cancer is a certainty). … READ MORE …

Getting your doctor(s) to talk to you about “the bad news”

There is an interesting article in the August 1 issue of the Journal of Clinical Oncology on why physicians and other health-care professionals don’t like to talk to their patients about “the bad news” when it comes to prognosis. … READ MORE …

ProstateVideos.com web site gets face-lift and update

For those who prefer to listen to their prostate cancer updates (as opposed to those that are happy to read) the video-based web site known as ProstateVideos.com has just completed a major overhaul. … READ MORE …